Cargando…

Prevalence and risk factors of depression in patients with drug-resistant tuberculosis in Nepal: A cross-sectional study

BACKGROUND: Patients with drug-resistant tuberculosis (DR TB) have a protracted course of illness and the available treatment has a low success rate. These factors combined with the associated stigma and financial implications put the patients with DR TB at an increased risk of depression. The psych...

Descripción completa

Detalles Bibliográficos
Autores principales: Shrestha, Sailesh Kumar, Joshi, Sulochana, Bhattarai, Ratna Bahadur, Joshi, Lok Raj, Adhikari, Nilaramba, Shrestha, Suvesh Kumar, Basnet, Rajendra, KC, Kedar Narsingh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649626/
https://www.ncbi.nlm.nih.gov/pubmed/33204854
http://dx.doi.org/10.1016/j.jctube.2020.100200
_version_ 1783607362776465408
author Shrestha, Sailesh Kumar
Joshi, Sulochana
Bhattarai, Ratna Bahadur
Joshi, Lok Raj
Adhikari, Nilaramba
Shrestha, Suvesh Kumar
Basnet, Rajendra
KC, Kedar Narsingh
author_facet Shrestha, Sailesh Kumar
Joshi, Sulochana
Bhattarai, Ratna Bahadur
Joshi, Lok Raj
Adhikari, Nilaramba
Shrestha, Suvesh Kumar
Basnet, Rajendra
KC, Kedar Narsingh
author_sort Shrestha, Sailesh Kumar
collection PubMed
description BACKGROUND: Patients with drug-resistant tuberculosis (DR TB) have a protracted course of illness and the available treatment has a low success rate. These factors combined with the associated stigma and financial implications put the patients with DR TB at an increased risk of depression. The psychiatric side effects of anti-tuberculosis drugs further aggravate the problem. This study aimed to estimate the prevalence of depression among patients with DR TB in Nepal and identify risk factors. METHODS: We conducted this cross-sectional study in April 2018 at all the functioning 11 programmatic DR TB treatment centers across Nepal. We selected 129 patients aged ≥ 16 years receiving treatment for DR TB by non-probability quota sampling. Six trained data collectors conducted face-to-face interviews and administered the Nepali language version of Patient Health Questionnaire 9 (PHQ-9) to screen for depression. We summarized sociodemographic and treatment characteristics with median (Interquartile Range [IQR]) and proportions as appropriate. We performed univariate analysis for the variables hypothesized as risk factors for depression. We fitted a multivariable binary logistic regression model with depression as the outcome variable and the variables with a significance level of < 0.25 as explanatory variables. We regarded a p-value of < 0.05 as significant for individual variables in the logistic regression model. RESULTS: Of the 129 patients studied, 92 (71.3%) were male and the median age was 36 years (IQR 25–48). The majority (109, 84.4%) had multi-drug resistant tuberculosis (MDR TB). We identified 81 patients (62.7%, 95% Confidence Interval [CI] 53.7–71) with the PHQ-9 score of 10 or more signifying probable depressive disorder. In univariate analyses, age, treatment center location, DR TB treatment duration, and duration of current illness had a p-value lower than the pre-specified cut-off of 0.25. In the multivariable logistic regression model, we found a statistically significant association of depression with the duration of illness (adjusted Odds Ratio 1.15, 95% CI 1.07–1.26, p < 0.001). CONCLUSION: This study has found that a large proportion of the patients with DR TB screened have depression suggesting the need for screening and management of comorbid depression within the National TB Control Program.
format Online
Article
Text
id pubmed-7649626
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-76496262020-11-16 Prevalence and risk factors of depression in patients with drug-resistant tuberculosis in Nepal: A cross-sectional study Shrestha, Sailesh Kumar Joshi, Sulochana Bhattarai, Ratna Bahadur Joshi, Lok Raj Adhikari, Nilaramba Shrestha, Suvesh Kumar Basnet, Rajendra KC, Kedar Narsingh J Clin Tuberc Other Mycobact Dis Article BACKGROUND: Patients with drug-resistant tuberculosis (DR TB) have a protracted course of illness and the available treatment has a low success rate. These factors combined with the associated stigma and financial implications put the patients with DR TB at an increased risk of depression. The psychiatric side effects of anti-tuberculosis drugs further aggravate the problem. This study aimed to estimate the prevalence of depression among patients with DR TB in Nepal and identify risk factors. METHODS: We conducted this cross-sectional study in April 2018 at all the functioning 11 programmatic DR TB treatment centers across Nepal. We selected 129 patients aged ≥ 16 years receiving treatment for DR TB by non-probability quota sampling. Six trained data collectors conducted face-to-face interviews and administered the Nepali language version of Patient Health Questionnaire 9 (PHQ-9) to screen for depression. We summarized sociodemographic and treatment characteristics with median (Interquartile Range [IQR]) and proportions as appropriate. We performed univariate analysis for the variables hypothesized as risk factors for depression. We fitted a multivariable binary logistic regression model with depression as the outcome variable and the variables with a significance level of < 0.25 as explanatory variables. We regarded a p-value of < 0.05 as significant for individual variables in the logistic regression model. RESULTS: Of the 129 patients studied, 92 (71.3%) were male and the median age was 36 years (IQR 25–48). The majority (109, 84.4%) had multi-drug resistant tuberculosis (MDR TB). We identified 81 patients (62.7%, 95% Confidence Interval [CI] 53.7–71) with the PHQ-9 score of 10 or more signifying probable depressive disorder. In univariate analyses, age, treatment center location, DR TB treatment duration, and duration of current illness had a p-value lower than the pre-specified cut-off of 0.25. In the multivariable logistic regression model, we found a statistically significant association of depression with the duration of illness (adjusted Odds Ratio 1.15, 95% CI 1.07–1.26, p < 0.001). CONCLUSION: This study has found that a large proportion of the patients with DR TB screened have depression suggesting the need for screening and management of comorbid depression within the National TB Control Program. Elsevier 2020-10-29 /pmc/articles/PMC7649626/ /pubmed/33204854 http://dx.doi.org/10.1016/j.jctube.2020.100200 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Shrestha, Sailesh Kumar
Joshi, Sulochana
Bhattarai, Ratna Bahadur
Joshi, Lok Raj
Adhikari, Nilaramba
Shrestha, Suvesh Kumar
Basnet, Rajendra
KC, Kedar Narsingh
Prevalence and risk factors of depression in patients with drug-resistant tuberculosis in Nepal: A cross-sectional study
title Prevalence and risk factors of depression in patients with drug-resistant tuberculosis in Nepal: A cross-sectional study
title_full Prevalence and risk factors of depression in patients with drug-resistant tuberculosis in Nepal: A cross-sectional study
title_fullStr Prevalence and risk factors of depression in patients with drug-resistant tuberculosis in Nepal: A cross-sectional study
title_full_unstemmed Prevalence and risk factors of depression in patients with drug-resistant tuberculosis in Nepal: A cross-sectional study
title_short Prevalence and risk factors of depression in patients with drug-resistant tuberculosis in Nepal: A cross-sectional study
title_sort prevalence and risk factors of depression in patients with drug-resistant tuberculosis in nepal: a cross-sectional study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649626/
https://www.ncbi.nlm.nih.gov/pubmed/33204854
http://dx.doi.org/10.1016/j.jctube.2020.100200
work_keys_str_mv AT shresthasaileshkumar prevalenceandriskfactorsofdepressioninpatientswithdrugresistanttuberculosisinnepalacrosssectionalstudy
AT joshisulochana prevalenceandriskfactorsofdepressioninpatientswithdrugresistanttuberculosisinnepalacrosssectionalstudy
AT bhattarairatnabahadur prevalenceandriskfactorsofdepressioninpatientswithdrugresistanttuberculosisinnepalacrosssectionalstudy
AT joshilokraj prevalenceandriskfactorsofdepressioninpatientswithdrugresistanttuberculosisinnepalacrosssectionalstudy
AT adhikarinilaramba prevalenceandriskfactorsofdepressioninpatientswithdrugresistanttuberculosisinnepalacrosssectionalstudy
AT shresthasuveshkumar prevalenceandriskfactorsofdepressioninpatientswithdrugresistanttuberculosisinnepalacrosssectionalstudy
AT basnetrajendra prevalenceandriskfactorsofdepressioninpatientswithdrugresistanttuberculosisinnepalacrosssectionalstudy
AT kckedarnarsingh prevalenceandriskfactorsofdepressioninpatientswithdrugresistanttuberculosisinnepalacrosssectionalstudy